Amino acid-based enantiomerically pure 3-substituted 1,4-benzodiazepin-2-ones: A new class of anti-ischemic agents

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 5, 2007, Pages 1326-1331

  Mishra, Jitendra Kumar ^a   Garg, Puja ^a   Dohare, Preeti ^a   Kumar, Ashutosh ^a   Siddiqi, Mohammad Imran ^a   Ray, Madhur ^a   Panda, Gautam ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

1,4 Benzodiazepin 2 ones; Amino acids; Anti ischemic agents

Indexed keywords

BENZODIAZEPIN 2 ONE DERIVATIVE; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL COUNT; CELL VIABILITY; DRUG ACTIVITY; ENANTIOMER; MOLECULAR MODEL; NERVE CELL; NEUROPROTECTION;

AMINO ACIDS; APOPTOSIS; BENZODIAZEPINONES; BINDING SITES; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; ISCHEMIA; MODELS, MOLECULAR; NEURONS; PROTEIN BINDING; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846928265     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.12.001     Document Type: Article

References (17)

1. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., and Moskowitz M.A. Science 265 (1994) 1883
2. Sternbach L.H. J. Med. Chem. 22 (1979) 1
3. Bock M.G., Dipardo R.M., Evans B.E., Rittle K.E., Whitter W.L., Veber D.E., Anderson P.S., and Freidinger R.M. J. Med. Chem. 32 (1989) 13
4. Kornecki E., Ehrlich Y.H., and Lenox R.H. Science 226 (1984) 1454
5. Bondinell, W. E.; Callahan, J. F.; Huffman, W. F.; Keenan, R. M.; Ku, T. W. F.; Newlander, K. A. 1993 Int. Patent Appl., WO 93/00095.
6. James G.L., Goldstein J.L., Brown M.S., Rawson T.E., Somers T.C., McDowell R.S., Crowley C.W., Lucas B.K., Levinson A.D., and Marsters J.C. Science 260 (1993) 1937
7. Advances in the Study of Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) Antitumour Antibiotics. In: Neidle S., and Waring M.J. (Eds). Molecular Aspects of Anticancer Drug-DNA Interactions Vol. 1 (1993), The Macmilan, London 54
8. Mishra J.K., and Panda G. Synthesis (2005) 1881
9. Oyama Y., Chikahisa L., Ueha T., Kanemaru K., and Noda K. Brain Res. 712 (1996) 349
10. Sureda F.X., Camins A., Trullas R., Camarasa J., and Escubedo E. Brain Res. 723 (1996) 110
11. Boldyrev A.A., Carpenter D.O., Huentelman M.J., Peters C.M., and Johnson P. Biochem. Biophys. Res. Commun. 256 (1999) 320
12. 16 at an excitation wavelengths of 488 nm and emission wavelength of 530 and 670 nm with Flow Cytometer (Becton-Dickinson, UK) and analyzed in a Cell Quest program. Those compounds showing >80% viable population of neurons, falling in the left lower quadrant, are considered active. Acquisition and analysis were performed with the Cell Quest software package (Becton-Dickinson, UK, Ltd).
13. Cerius2 Version 4.10, Accelrys Inc.: 9685 Scranton Rd., San Diego, CA 92121, U.S.A., http://www.accelrys.com.
14. Tarnawa I., Molnar P., Gaal L., and Andrasi F. Acta Physiol. Hung. 79 (1992) 163
15. Donevan S.D., and Rogawski M.A. Neuron 10 (1993) 51
16. Maple J.R., Hwang M.J., Stockfish T.P., Dinur U., Waldman M., Ewig C.S., and Hagler A.T. J. Comput. Chem. 15 (1994) 161
17. Armstrong N., and Gouaux E. Neuron 28 (2000) 165